Prevalence of Ascending Aortic Dilation in Sports Medicine
NCT ID: NCT07050953
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2024-01-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Point-of-Care Focused Cardiac Ultrasound in Assessing the Thoracic Aorta
NCT01671618
Aortic Dimensions in Patients With Fabry Disease
NCT06956573
Intracardiac Flow Remodeling in Athletes
NCT03076788
Risk of Sudden Cardiac Death in UN Athletes
NCT06518252
Ventricular Arrhythmia After Myocarditis in Sportsman
NCT03842592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is an observational study conducted at the Sports Medicine Department of Caen University Hospital (France). The study will include athletes over the age of 10 who consult for a pre-participation medical evaluation. A focused cardiac ultrasound (FCU) protocol targeting the ascending aorta will be systematically performed using a portable ultrasound device during routine clinical assessment. When indicated, a standard transthoracic echocardiography (TTE) will be used as the reference method for comparison.
The primary objective of the study is to estimate the prevalence of ascending aortic dilation in this population. The secondary objective is to explore potential predictive factors, including cardiovascular risk factors and exercise history.
This study may help clarify the utility of FCU as a screening tool in sports medicine and contribute to improved early detection of aortic abnormalities in apparently healthy, physically active individuals. Further research may be warranted to assess long-term cardiovascular outcomes in this population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recreational and competitive Athletes
All athletes aged over 10 years consulting for routine sports medicine evaluation, regardless of sport type or performance level.
focused cardiac ultrasound
A focused cardiac ultrasound will be performed to measure the dimensions of ascending aorta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
focused cardiac ultrasound
A focused cardiac ultrasound will be performed to measure the dimensions of ascending aorta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consulting for a pre-participation sports medicine evaluation at the Caen University Hospital
* No known history of cardiovascular disease
* Underwent a focused cardiac ultrasound (FCU) of the ascending aorta as part of the consultation
* Consent given for use of anonymized medical data for research purposes
Exclusion Criteria
* Incomplete or non-interpretable FCU images
* Existing cardiology follow-up with echocardiography less than 3 years old
* Refusal to participate or opposition to data use
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Caen Normandie
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ao-TTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.